NEW YORK (GenomeWeb News) – Tute Genomics said this week that it has raised $1.5 million in a seed round of funding to advance its genome analysis software.

The company also said that it raised an additional $300,000 from AngelList, a fundraising platform for startups, through its new syndicate mechanism.

Investors in the seed round included Wilmington Pharmatech, Salt Lake Life Science Angels, Peak Ventures, Park City Angel Network, and individual angel investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.